Aethlon Medical Inc Net debt/EBITDA
Mi az Aethlon Medical Inc Net debt/EBITDA?
A Net debt/EBITDA az Aethlon Medical Inc - 7.42
Mi a Net debt/EBITDA meghatározása?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA a Industrials szektor a NASDAQ-on cégekben a Aethlon Medical Inc -hoz képest
Mit csinál Aethlon Medical Inc?
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
net debt/ebitda -hoz hasonló cégek Aethlon Medical Inc
- Allison Transmission Inc nak Net debt/EBITDA 7.40 van
- China High Speed Transmission Equipment Co nak Net debt/EBITDA 7.41 van
- National Services Reunited Corp nak Net debt/EBITDA 7.41 van
- Rose Hill Acquisition Corp nak Net debt/EBITDA 7.41 van
- Vulcan Materials Co nak Net debt/EBITDA 7.41 van
- Dycom Industries nak Net debt/EBITDA 7.41 van
- Aethlon Medical Inc nak Net debt/EBITDA 7.42 van
- Ardelyx Inc nak Net debt/EBITDA 7.42 van
- Foghorn Therapeutics nak Net debt/EBITDA 7.42 van
- Kirby nak Net debt/EBITDA 7.42 van
- Verisk Analytics Inc nak Net debt/EBITDA 7.43 van
- Tullow Oil plc nak Net debt/EBITDA 7.43 van
- Adecco AG nak Net debt/EBITDA 7.43 van